Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Eur J Histochem ; 59(4): 2569, 2015 Nov 26.
Article in English | MEDLINE | ID: mdl-26708184

ABSTRACT

The development of the synovial membrane was analyzed in serial sections of 21 temporomandibular joints of human fetuses at 9 to 13 weeks of gestation. Sections of two fetuses at 12 weeks of development were used to perform immunohistochemical expression of the markers CD68 and Hsp27 on the synovial lining. Macrophage-like type A and fibroblast-like type B cells, which express CD68 and Hsp27, respectively, were observed at the twelfth week of development. Our results suggest that the development of the synovial membrane is related to the vascularization of the joint and the formation of the articular cavities.


Subject(s)
Antigens, CD/biosynthesis , Antigens, Differentiation, Myelomonocytic/biosynthesis , Fetus/embryology , Gene Expression Regulation, Developmental/physiology , HSP27 Heat-Shock Proteins/biosynthesis , Synovial Membrane/embryology , Temporomandibular Joint/embryology , Female , Fetus/cytology , Heat-Shock Proteins , Humans , Immunohistochemistry/methods , Male , Molecular Chaperones , Synovial Membrane/cytology , Temporomandibular Joint/cytology
2.
J Intern Med ; 265(2): 266-74, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18793248

ABSTRACT

BACKGROUND: High oxygen-affinity haemoglobin variants and 2,3-diphosphoglycerate (2,3-DPG) deficiency are inherited diseases generating low tissue oxygen tension and erythropoietin-driven erythrocytosis, that characterizes the clinical phenotype of patients. Level of blood p50 (the oxygen tension at which haemoglobin is 50% saturated) is used to recognize these conditions. OBJECTIVES: To define the clinical utility of blood p50 measurement in the diagnosis of isolated erythrocytosis. SUBJECTS AND DESIGN: Venous blood p50 measurement was included in the diagnostic work-up of 102 consecutive patients with isolated erythrocytosis besides blood cell count, arterial oxygen saturation, serum erythropoietin measurement and screening for JAK2 mutations. SETTING: Haematological Outpatient Section at University Hospital. RESULTS: Seven patients had relative erythrocytosis. Among 95 patients with absolute erythrocytosis, 4 (4.2%) had decreased p50 level. The extended study of family members revealed a familial inheritance. Two families had haemoglobin variants already described as Haemoglobin Malmö and Haemoglobin San Diego. In one family, the proband had a new high oxygen-affinity haemoglobin variant (Haemoglobin Safi) resulting from the transversion C-->A at codon 81 of the alpha2-globin gene. In the last family, a deficiency of 2,3-DPG was found. Within the 91 patients with normal p50 values, 46 (51%) had secondary erythrocytosis, 13 (14%) polycythemia vera and 32 (35%) idiopathic erythrocytosis. CONCLUSIONS: This study suggests that the investigation of blood p50 level may be useful to define diagnosis in patients with isolated erythrocytosis.


Subject(s)
Erythropoietin/blood , Oxygen/blood , Polycythemia/blood , Adult , Algorithms , Biomarkers/blood , Blood Cell Count , Blood Gas Analysis , Female , Hemoglobins, Abnormal/genetics , Humans , Janus Kinase 2/blood , Janus Kinase 2/genetics , Male , Middle Aged , Polycythemia/diagnosis , Young Adult
3.
Micron ; 39(8): 1335-41, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18343675

ABSTRACT

Toxoplasma gondii, an obligate intracellular protozoan parasite, infects most species of warm-blooded animals, and in humans it causes toxoplasmosis. Healthy people that become infected rarely present clinical symptoms because the immune system prevents the parasite from causing illness. Congenital toxoplasmosis may result in abortion, hydrocephalus, as well as neurological and ocular disease (most frequently retinochoroiditis) of the newborn. In immunocompromised patients, reactivation of latent disease can cause encephalitis. Cell-mediated immunity to T. gondii antigens involves innate acute inflammatory responses and antigen-specific adaptive immunity. Considering the complexity of the immunological events triggered during toxoplasmosis, systemic and local responses were evaluated by cytokine measurements. Aqueous humour and serum were obtained from non-infected and T. gondii Me-49 strain infected C57BL/6 mice for cytokine quantification. Histopathological analyses were made with eyes enucleated from mice after 30 days of infection. ELISA assays showed an increase of IFN-gamma levels both in serum and aqueous humour of infected mice in opposition to a decrease in IL-10 levels. On the other hand, TGF-beta was high, whereas IL-12 and TNF-alpha were present in small levels in both groups. We also detected higher levels of IL-4 and IL-6 in aqueous humour than in serum of infected mice when compared to the control group. MIP-2 presented no significant differences between the two groups. Fas and Fas-L were also present in similar levels in serum of non-infected and infected mice, but both chemokines were increased in the aqueous humour of infected mice. Histopathological analysis of infected mice showed inflammatory infiltrates around blood vessels and alteration of the outer photoreceptor segments, on the external and inner nuclear layer. Parasites were observed in 82% of eyes, inside the blood vessels associated with inflammatory infiltrate. Edema, characterized by the increase of interstitial spaces between the FTR, forming lacunae was also noted. These alterations take the form of projections (retino-vitreal), characteristic of retinochoroiditis. In conclusion, T. gondii infection of C57BL/6 mice revealed that cytokine patterns alone do not assure susceptibility or resistance against infection, thus reinforcing the notion that it is necessary more than cytokine dosage to determine Th1 or Th2 profile in this model.


Subject(s)
Aqueous Humor/immunology , Cytokines/biosynthesis , Toxoplasmosis, Ocular/immunology , Toxoplasmosis, Ocular/pathology , Animals , Cytokines/blood , Female , Fluorescent Antibody Technique, Indirect , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Mice , Mice, Inbred C57BL , Transforming Growth Factor beta1/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis
4.
Micron ; 38(7): 729-33, 2007.
Article in English | MEDLINE | ID: mdl-17596951

ABSTRACT

Ocular toxoplasmosis is present in 20% of infected immunocompetent individuals. Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to be linked to human lesions in the eye. An experimental model for congenital ocular toxoplasmosis was developed in C57BL/6 mice with the purpose to evaluate Toxoplasma induced ocular pathology during fetal life. Toxoplasma gondii, ME-49 strain, was used to infect pregnant females. Histological analysis of pre-natal fetal eyes from infected female mice, did not show parasite infestation, however, alterations were observed in the outer nuclear layer (ONL) and in the inner nuclear layers (INL) of the retina. Edema was also observed, characterized by the increase of interstitial spaces forming lacunae between the ONL and INL cells and a net of vessels associated with an intense inflammatory infiltrate. These histological observations suggest that ocular lesions are not delayed manifestations of toxoplasmosis. The eye was affected in the initial phase of disease, and these alterations were of similar nature as those observed in mice at later stages of infection.


Subject(s)
Embryo, Mammalian/pathology , Toxoplasmosis, Ocular/congenital , Toxoplasmosis, Ocular/pathology , Animals , Disease Models, Animal , Female , Inflammation/pathology , Male , Mice , Mice, Inbred C57BL , Pregnancy , Retina/pathology
5.
Parasitology ; 131(Pt 3): 303-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16178351

ABSTRACT

This paper aims to test the influence of route of infection (intravitreal and instillation) on the course of ocular toxoplasmosis in mice, using the Toxoplasma gondii Me-49 strain. All mice inoculated intravitreally or by instillation presented the same pattern of infection. Using either route, parasites were observed in the retinal vessel with the formation of a glial reaction in the inner plexiforme layer and discontinuity of the pigmented epithelium of the retina 7 days after infection. However, when the intravitreal route was used a more intense inflammatory infiltrate was observed in the retina. The results suggest that inoculation route remarkably influences the inflammatory pattern in ocular toxoplasmosis and that the instillation route should be preferentially used in experimental infections in the murine ocular model of infection by T. gondii, specially with small animals where there is extensive needle damage, which is not observed in the instillation route.


Subject(s)
Toxoplasmosis, Ocular/physiopathology , Toxoplasmosis, Ocular/parasitology , Animals , Female , Mice , Mice, Inbred C57BL , Retina/parasitology , Retina/pathology
6.
Parasitology ; 128(Pt 4): 385-90, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15151143

ABSTRACT

Here we describe extracellular matrix alterations in footpad lesions and draining lymph nodes caused by Leishmania (L.) amazonensis in mouse strains with distinct susceptibilities to this parasite: BALB/c (susceptible), C57BL/6 (intermediate), and DBA/2 (resistant). Changes in ECM were observed mainly in BALB/c mice that, in general, presented tissue damage associated with high parasite burden. Under polarized light, Sirius Red revealed type I collagen that was predominant in the primary lesion in all strains studied at the early phase of infection, but gradually decreased and was replaced by abundant type III collagen fibres in chronic phase lesions. The presence of type III collagen seemed to provide support to inflammatory cells, mainly vacuolated and parasitized macrophages. Laminin expression was not altered during infection by L. (L.) amazonensis in any of the mouse strains studied. Furthermore, the decreased fibronectin expression, in all strains, in areas where amastigotes have been found, indicated that this decline was also not related to the genetic background.


Subject(s)
Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Leishmania/growth & development , Leishmaniasis/metabolism , Leishmaniasis/pathology , Animals , Collagen Type I/metabolism , Collagen Type III/metabolism , Extracellular Matrix/parasitology , Female , Fibronectins/metabolism , Genetic Predisposition to Disease , Humans , Immunohistochemistry , Laminin/metabolism , Leishmaniasis/parasitology , Lymph Nodes/parasitology , Lymph Nodes/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred DBA , Skin/parasitology , Skin/pathology
7.
Parasitol Res ; 92(6): 467-72, 2004 Apr.
Article in English | MEDLINE | ID: mdl-14986110

ABSTRACT

Our aim was to study the migration of retinal pigmented epithelium (RPE) into the retinal layer during infection of C57BL/6 mice with Toxoplasma gondii. Eyes from infected and non-infected animals were analyzed on the 60th day of infection by light and transmission electron microscopy. Non-infected eyes showed a normal morphology. In contrast, we observed free parasites in the retinal vasculature, the presence of mononuclear inflammatory infiltrate (MNII) and parasites in the vasculature of choroids in infected eyes. No inflammatory infiltrate was observed; RPE cells were identified near the MNII in nuclear and plexiforme layers. RPE cells were also found on the ganglion cell layer and in the outer segments of the photoreceptor. The morphology showed that RPE cells caused a discontinuity in the nuclear and plexiforme layers. Clusters of parasites were found surrounded by RPE cells and MNII in the inner plexiforme layers. Ultrastructural analysis showed that RPE cells migrated through the epithelium into the inner retinal layers. We did not observe Toxoplasma cysts in many eyes in which pathological changes were detected. Only 8.3% of the animals had Toxoplasma cysts in the inner nuclear layer in the absence of inflammatory cells. The migration of RPE cells can be triggered by a disruption of the RPE monolayer or injury to the neural retina, as in the case of toxoplasmosis.


Subject(s)
Pigment Epithelium of Eye/pathology , Pigment Epithelium of Eye/parasitology , Toxoplasma/pathogenicity , Toxoplasmosis, Ocular/pathology , Toxoplasmosis, Ocular/parasitology , Animals , Cell Movement , Choroid/parasitology , Choroid/pathology , Eye/parasitology , Eye/pathology , Leukocytes, Mononuclear/immunology , Mice , Mice, Inbred C57BL , Microscopy , Microscopy, Electron , Retina/parasitology , Retina/pathology , Retinal Vessels/parasitology , Retinal Vessels/pathology
8.
Am J Trop Med Hyg ; 68(6): 661-5, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12887024

ABSTRACT

We describe the pathologic alterations of the central nervous system (CNS) observed in experimental tegumentary leishmaniasis in BALB/c and Swiss mice. The mice were subcutaneously infected with 10(4) amastigotes of Leishmania (Leishmania) amazonensis. Animals were killed and brains were removed for histologic and immunocytochemical studies. Histologic examination showed that 66.6% of infected mice had a discrete hyperemia and inflammatory infiltrate in the meninges, composed of mononuclear cells and neutrophils with no detectable parasites. However, parasitized macrophages were detected in the cerebral parenchyma, as well as mast cells, lymphocytes, and polymorphonuclear cells. Necrosis in the cerebral parenchyma was also observed. Confocal fluorescence microscopy showed that CD8+ T lymphocytes are the major component of the inflammatory infiltrate in the CNS. In addition to these cells, CD4+, CD11b, and dendritic cells are present, in small numbers, in the inflammatory processes of the CNS. Thus, L. amazonensis is able to cross the blood-brain barrier and cause significant pathologic changes in the CNS.


Subject(s)
Central Nervous System Protozoal Infections/pathology , Central Nervous System Protozoal Infections/parasitology , Leishmania/pathogenicity , Leishmaniasis/pathology , Leishmaniasis/parasitology , Animals , Brain/parasitology , Brain/pathology , Central Nervous System Protozoal Infections/physiopathology , Encephalitis/parasitology , Encephalitis/pathology , Encephalitis/physiopathology , Female , Immunohistochemistry , Leishmaniasis/physiopathology , Mice , Mice, Inbred BALB C , Microscopy, Confocal
9.
Pathol Biol (Paris) ; 51(3): 129-34, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12781792

ABSTRACT

In this article, we have characterized cell subpopulations found in the hearts of mice presenting acute Chagas' disease by immunocytochemistry and subjected to different schedules of an immunosuppressive therapy with cyclophosphamide (CY). In this comparative study, CY treatment with different doses was carried out before or after infection with Trypanosoma cruzi Y strain trypomastigotes, enabling us to discriminate the parasitemic kinetics and inflammatory processes in the heart, 12 d after infection. Animals treated with 200 mg/kg of CY 2 d before infection presented high parasitaemia as well as heavy inflammation and low parasite loads in the heart. Mice treated 5 d after infection with the same dose, developed the same parasitaemic peak but were not able to control it. Their heart did not present inflammation, but a high number of parasites could be seen. Animals treated with five 3 mg/kg doses of CY every other day presented heavy inflammatory reaction and low parasitaemia. In this group, as well as the one treated before infection, immunocytochemistry studies have shown predominance of CD8(+) T cells in the myocardium. On the other hand, mice treated with 200 mg/kg of CY 5 d after infection, presented small amounts of CD4(+) T cells while no CD8(+) could be found. These results have confirmed the dose dependence influence of this drug on the T cell populations in the inflammatory infiltrates as well as the importance of the schedule employed.


Subject(s)
Chagas Cardiomyopathy/pathology , Cyclophosphamide/therapeutic use , Immunosuppressive Agents/therapeutic use , Myocardium/pathology , T-Lymphocytes/pathology , Trypanosoma cruzi , Animals , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/pathology , Chagas Cardiomyopathy/mortality , Cyclophosphamide/administration & dosage , Female , Fluorescent Antibody Technique , Immunosuppressive Agents/administration & dosage , Macrophages/pathology , Mice , Microscopy, Confocal , Parasitemia
10.
Eur J Pharmacol ; 431(2): 189-200, 2001 Nov 16.
Article in English | MEDLINE | ID: mdl-11728425

ABSTRACT

The present studies were designed to assess whether the novel muscarinic M(2) receptor antagonist 4-cyclohexyl-alpha-[4[[4-methoxyphenyl]sulphinyl]-phenyl]-1-piperazineacetonitrile (SCH 57790) could increase acetylcholine release in the central nervous system (CNS) and enhance cognitive performance in rodents and nonhuman primates. In vivo microdialysis studies show that SCH 57790 (0.1-10 mg/kg, p.o.) produced dose-related increases in acetylcholine release from rat hippocampus, cortex, and striatum. SCH 57790 (0.003-1.0 mg/kg) increased retention times in young rat passive avoidance responding when given either before or after training. Also, SCH 57790 reversed scopolamine-induced deficits in mice in a passive avoidance task. In a working memory operant task in squirrel monkeys, administration of SCH 57790 (0.01-0.03 mg/kg) improved performance under a schedule of fixed-ratio discrimination with titrating delay. The effects observed with SCH 57790 in behavioral studies were qualitatively similar to the effects produced by the clinically used cholinesterase inhibitor donepezil, suggesting that blockade of muscarinic M(2) receptors is a viable approach to enhancing cognitive performance.


Subject(s)
Acetylcholine/metabolism , Cognition/drug effects , Muscarinic Antagonists/pharmacology , Piperazines/pharmacology , Receptors, Muscarinic/drug effects , Animals , Blood Pressure/drug effects , Brain/drug effects , Brain/metabolism , CHO Cells , Cricetinae , Heart Rate/drug effects , Male , Mice , Microdialysis , Molecular Structure , Piperazines/chemistry , Rats , Rats, Sprague-Dawley , Receptor, Muscarinic M2 , Saimiri , Scopolamine/pharmacology , Time Factors
11.
G Ital Med Lav Ergon ; 23(1): 43-51, 2001.
Article in Italian | MEDLINE | ID: mdl-11386186

ABSTRACT

In this article the cases of occupational allergic diseases notified to 2 Occupational Health Units in Pavia in the period 1993-1998 are reported. A retrospective study was performed to obtain a descriptive analysis of the diseases. In the studied period 58 cases of occupational allergic diseases were notified. This datum probably underestimates the real occurrence of occupational diseases, because of the low accuracy of the notification system. Allergic skin diseases were more frequent (70.7%) than respiratory diseases.


Subject(s)
Hypersensitivity/epidemiology , Occupational Diseases/epidemiology , Adult , Female , Humans , Hypersensitivity/classification , Hypersensitivity/diagnosis , Hypersensitivity/etiology , Italy , Male , Occupational Diseases/classification , Occupational Diseases/diagnosis , Occupational Diseases/etiology , Retrospective Studies
12.
Bioorg Med Chem Lett ; 11(10): 1281-4, 2001 May 21.
Article in English | MEDLINE | ID: mdl-11392537

ABSTRACT

To prepare novel estrogen receptor (ER) ligands, we have developed a facile approach to substituted hexahydrochrysene and tetrahydrobenzo[a]fluorene systems. Substituents, including basic side chains, were added to these systems, and their binding affinity to ERalpha and ERbeta, and in some cases their transcriptional activity were evaluated.


Subject(s)
Chrysenes/chemical synthesis , Fluorenes/chemical synthesis , Receptors, Estrogen/drug effects , Chrysenes/pharmacology , Estrogen Receptor alpha , Estrogen Receptor beta , Fluorenes/pharmacology , Humans , Ligands , Molecular Conformation , Polycyclic Compounds/chemical synthesis , Polycyclic Compounds/metabolism , Polycyclic Compounds/pharmacology , Protein Binding , Receptors, Estrogen/agonists , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/metabolism , Structure-Activity Relationship , Transcription, Genetic/drug effects , Tumor Cells, Cultured/drug effects
13.
Chem Biol ; 8(3): 277-87, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11306352

ABSTRACT

BACKGROUND: The specificity of hormone action arises from complementary steric and electronic interactions between a hormonal ligand and its cognate receptor. An analysis of such key ligand-receptor contact sites, often delineated by mutational mapping and X-ray crystallographic studies, can suggest ways in which hormone-receptor specificity might be altered. RESULTS: We have altered the hormonal specificity of the estrogen receptor alpha (ER) by making 'coordinated' changes in the A-ring of the ligand estradiol and in the A-ring binding subpocket of ER. These changes were designed to maintain a favorable interaction when both E and ER are changed, but to disfavor interaction when only E or ER is changed. We have evaluated several of these altered ligand and receptor pairs in quantitative ligand binding and reporter gene assays. CONCLUSIONS: In best cases, the new interaction is sufficiently favorable and orthogonal so as to represent the creation of a new hormone specificity, which might be useful in the regulation of transgene activity.


Subject(s)
Drug Design , Receptors, Estrogen/chemistry , Animals , Binding Sites , Dose-Response Relationship, Drug , Estrogens/chemical synthesis , Estrogens/chemistry , Estrogens/metabolism , Humans , Ligands , Models, Molecular , Molecular Structure , Mutagenesis, Site-Directed , Protein Binding , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Structure-Activity Relationship , Substrate Specificity
14.
Bioorg Med Chem ; 9(1): 141-50, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11197334

ABSTRACT

Previously, we reported that certain tetrasubstituted 1,3,5-triaryl-4-alkyl-pyrazoles bind to the estrogen receptor (ER) with high affinity (Fink, B. E.; Mortenson, D. S.; Stauffer, S. R.; Aron, Z. D.; Katzenellenbogen, J. A. Chem. Biol. 1999, 6, 205-219; Stauffer, S. R.; Katzenellenbogen, J. A. J. Comb/. Chem. 2000, 2. 318 329; Stauffer, S. R.: Coletta, C. J.: Sun, J.; Tedesco, R., Katzenellenbogen, B. S.; Katzenellenbogen, J. A. J. Med. Chem. 2000, submitted). To investigate how cyclic permutation of the two nitrogen atoms of a pyrazole might affect ER binding affinity, we prepared a new pyrazole core isomer, namely a 1,3,4-triaryl-5-alkyl-pyrazole (2), to compare it with our original pyrazole (1). We also prepared several peripherally matched core pyrazole isomer sets to investigate whether the two pyrazole series share a common binding orientation. Our efficient, regioselective synthetic route to these pyrazoles relies on the acylation of a hydrazone anion, followed by cyclization, halogenation, and Suzuki coupling. We found that the ER accommodates 1,3,4-triaryl-pyrazoles of the isomeric series only somewhat less well than the original 1,3,5-triaryl series, and it appears that both series share a common binding mode. This preferred orientation for the 1,3,5-triaryl-4-alkyl-pyrazoles is supported by binding affinity measurements of analogues in which the phenolic hydroxyl groups were systematically removed from each of the three aryl groups, and the orientation is consistent, as well, with molecular modeling studies. These studies provide additional insight into the design of heterocyclic core structures for the development of high affinity ER ligands by combinatorial methods.


Subject(s)
Estrogens/chemistry , Pyrazoles/chemical synthesis , Receptors, Estrogen/drug effects , Animals , Binding Sites , Binding, Competitive , Isomerism , Ligands , Magnetic Resonance Spectroscopy , Models, Molecular , Radioligand Assay , Receptors, Estrogen/chemistry , Sheep
15.
Immunopharmacology ; 47(1): 1-11, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10708805

ABSTRACT

The in vivo effects of cyclosporin A (CsA) on Trypanosoma cruzi infection were examined using different schedules of the drug in mice infected with the Y strain. Parasitaemia at day 8 after infection among CsA-treated animals was usually higher than control infected non-treated mice. On the other hand, mortality analysis showed that animals CsA-treated either with 200 mg/kg 2 days before infection or with therapeutic doses (10 mg/kg every other day) showed almost the same mean time of death (35.8 and 38.2 days, respectively). In these groups mice died 50% less than control infected non-treated ones. The mean time of death in the animals treated with 200 mg/kg 5 days after infection and in infected non-treated control mice were respectively 29.0 and 22.6 days. The kinetics analysis of the leukocyte population of animals treated with a single dose of 200 mg/kg of CsA before or after infection did not show the alternate pattern of leukopenia/leukocytosis observed in control groups of infected mice but differential cell counts indicated a modulatory action upon circulating leukocytes of therapeutic doses of CsA. The animals treated with any of the CsA schedules showed a moderate to intense diffuse inflammatory reaction exhibiting mainly mononuclear cells in the heart. Immunofluorescence analysis by confocal microscopy revealed that macrophages are a major component of the inflammatory infiltrate in all groups of CsA-treated mice and also in the control group.


Subject(s)
Chagas Disease/drug therapy , Cyclosporine/pharmacology , Acute Disease , Animals , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/physiology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/physiology , Cell Movement , Chagas Disease/mortality , Cyclosporine/therapeutic use , Female , Immunohistochemistry , Immunosuppressive Agents/pharmacology , Immunosuppressive Agents/therapeutic use , Kinetics , Leukocyte Count/drug effects , Lymphocyte Count/drug effects , Macrophages/drug effects , Macrophages/physiology , Mice , Microscopy, Confocal , Monocytes/cytology , Monocytes/drug effects , Myocarditis/drug therapy , Myocarditis/parasitology , Myocardium/pathology , Organ Size/drug effects , Parasitemia/drug therapy , Spleen/pathology , Thymus Gland/pathology , Time Factors , Trypanosomiasis/drug therapy , Trypanosomiasis/mortality
16.
J Med Chem ; 43(26): 4934-47, 2000 Dec 28.
Article in English | MEDLINE | ID: mdl-11150164

ABSTRACT

We have found that certain tetrasubstituted pyrazoles are high-affinity ligands for the estrogen receptor (ER) (Fink et al. Chem. Biol. 1999, 6, 205-219) and that one pyrazole is considerably more potent as an agonist on the ERalpha than on the ERbeta subtype (Sun et al. Endocrinology 1999, 140, 800-804). To investigate what substituent pattern provides optimal ER binding affinity and the greatest enhancement of potency as an ERalpha-selective agonist, we prepared a number of tetrasubstituted pyrazole analogues with defined variations at certain substituent positions. Analysis of their binding affinity pattern shows that a C(4)-propyl substituent is optimal and that a p-hydroxyl group on the N(1)-phenyl group also enhances affinity and selectivity for ERalpha. The best compound in this series, a propylpyrazole triol (PPT, compound 4g), binds to ERalpha with high affinity (ca. 50% that of estradiol), and it has a 410-fold binding affinity preference for ERalpha. It also activates gene transcription only through ERalpha. Thus, this compound represents the first ERalpha-specific agonist. We investigated the molecular basis for the exceptional ERalpha binding affinity and potency selectivity of pyrazole 4g by a further study of structure-affinity relationships in this series and by molecular modeling. These investigations suggest that the pyrazole triols prefer to bind to ERalpha with their C(3)-phenol in the estradiol A-ring binding pocket and that binding selectivity results from differences in the interaction of the pyrazole core and C(4)-propyl group with portions of the receptor where ERalpha has a smaller residue than ERbeta. These ER subtype-specific interactions and the ER subtype-selective ligands that can be derived from them should prove useful in defining those biological activities in estrogen target cells that can be selectively activated through ERalpha.


Subject(s)
Phenols/chemical synthesis , Pyrazoles/chemical synthesis , Receptors, Estrogen/agonists , Binding, Competitive , Estrogen Receptor alpha , Humans , Ligands , Models, Molecular , Phenols/chemistry , Phenols/metabolism , Phenols/pharmacology , Pyrazoles/chemistry , Pyrazoles/metabolism , Pyrazoles/pharmacology , Radioligand Assay , Structure-Activity Relationship , Transcriptional Activation , Tumor Cells, Cultured
17.
Peptides ; 19(5): 869-75, 1998.
Article in English | MEDLINE | ID: mdl-9663452

ABSTRACT

Intracerebroventricular (i.c.v.) administration of glucagon-like peptide-1-(7-37) amide (GLP-1) has been shown to modulate food and water intake. The present studies further characterize the effects of i.c.v. GLP-1 in the regulation of energy balance in lean and obese animals. In both obese and lean Zucker rats, a single i.c.v. infusion of GLP-1 (1-30 microg) resulted in a dose-dependent reduction of food intake and decrease in respiratory quotient relative to the saline control during the first 2 h of the nocturnal cycle. In obese Zucker rats, the food intake was reduced by 73 +/- 11% of the control at the 30 microg dose, whereas a modest 45 +/- 18% reduction was observed in lean rats. Despite the large reduction in food intake seen with GLP-1, there was no compensatory decrease in nocturnal oxygen consumption in the obese Zucker rats. Interestingly, low doses of GLP-1 (1 microg) in lean Zucker rats, which had minimal effects on food intake, caused a 19 +/- 7% increase in O2 consumption during the first 2 h of the nocturnal cycle. These data suggest that central GLP-1 may be an important factor controlling negative energy balance in both the lean and obese Zucker rats.


Subject(s)
Drinking Behavior/drug effects , Energy Metabolism/drug effects , Feeding Behavior/drug effects , Glucagon/pharmacology , Obesity/genetics , Peptide Fragments/pharmacology , Protein Precursors/pharmacology , Analysis of Variance , Animals , Glucagon-Like Peptide 1 , Injections, Intraventricular , Male , Rats , Rats, Zucker
18.
Eur J Pharmacol ; 349(2-3): 237-43, 1998 May 22.
Article in English | MEDLINE | ID: mdl-9671103

ABSTRACT

The hemodynamic and platelet effects of the thrombin receptor activating peptide SFLLRN (TRAP) were evaluated in rats. TRAP failed to aggregate rat platelets in vitro (platelet rich plasma) or in vivo in the pulmonary microcirculation. In contrast, TRAP aggregated washed human platelets. Intravenous injection of TRAP (1 mg/kg) in inactin-anesthetized rats produced a biphasic response in blood pressure characterized by an initial depressor response (-25 +/- 3 mmHg for 15-30 s) followed by a pronounced pressor response (50 +/- 7 mmHg for 2-3 min). This increase in blood pressure can be attributed to increases in total peripheral resistance since cardiac output remained unchanged. Further, only the pressor responses were observed in pithed rats suggesting a direct effect of TRAP in causing smooth muscle contraction. Consequently, rat platelets differ from human platelets in that they are resistant to TRAP whereas rat vasculature is highly sensitive to TRAP. These observations suggest that while the thrombin receptors on rat vasculature may be similar to those on human platelets, the receptors and/or the coupling mechanisms in rat platelets appear different from human platelets.


Subject(s)
Blood Platelets/drug effects , Blood Pressure/drug effects , Heart Rate/drug effects , Peptide Fragments/pharmacology , Animals , Blood Platelets/physiology , Decerebrate State , Humans , Lung/blood supply , Lung/drug effects , Male , Microcirculation/drug effects , Platelet Aggregation , Rats , Stimulation, Chemical
19.
J Clin Invest ; 99(3): 385-90, 1997 Feb 01.
Article in English | MEDLINE | ID: mdl-9022070

ABSTRACT

Leptin administration reduces obesity in leptin-deficient ob/ob mice; its effects in obese humans, who have high circulating leptin levels, remain to be determined. This longitudinal study was designed to determine whether diet-induced obesity in mice produces resistance to peripheral and/or central leptin treatment. Obesity was induced in two strains of mice by exposure to a 45% fat diet. Serum leptin increased in proportion to body weight (P < 0.00001). Whereas C57BL/6 mice initially responded to peripherally administered leptin with a marked decrease in food intake, leptin resistance developed after 16 d on high fat diet; mice on 10% fat diet retained leptin sensitivity. In AKR mice, peripheral leptin significantly decreased food intake in both 10 and 45% fat-fed mice after 16 d of dietary treatment. However, after 56 d, both groups became resistant to peripherally administered leptin. Central administration of leptin to peripherally leptin-resistant AKR mice on 45% fat diet resulted in a robust response to leptin, with a dose-dependent decrease in food intake (P < 0.00001) and body weight (P < 0.0001) after a single intracerebroventricular infusion. These data demonstrate that, in a diet-induced obesity model, mice exhibit resistance to peripherally administered leptin, while retaining sensitivity to centrally administered leptin.


Subject(s)
Obesity/drug therapy , Proteins/administration & dosage , Proteins/therapeutic use , Animals , Appetite Regulation/drug effects , Body Weight/drug effects , Dietary Fats/administration & dosage , Dietary Fats/adverse effects , Dose-Response Relationship, Drug , Drug Resistance , Eating/drug effects , Feeding Behavior/drug effects , Leptin , Longitudinal Studies , Male , Mice , Mice, Inbred AKR , Mice, Inbred C57BL , Obesity/blood , Proteins/analysis , Time Factors
20.
J Eukaryot Microbiol ; 43(4): 275-85, 1996.
Article in English | MEDLINE | ID: mdl-8768431

ABSTRACT

Upon incubation at 37 degrees C onto glass coverslips coated with Concanavalin A, poly-L-lysine, or a monoclonal antibody (1D9) directed to the parasite major surface glycoprotein Ssp-4, extracellular Trypanosoma cruzi amastigotes release trails of material barely visible by light microscopy. This release is not associated with parasite movements. Immunolabeling studies confirmed that the material is derived from the parasite's membrane since thin section through samples labeled with 1D9 revealed that the trails are membrane-bound structures. Scanning electron microscopy showed that the approximately 0.1-micron(s) thick trails of material emerging from the amastigotes can be uniform or beaded, indicating a tendency to vesiculation. The trails are preferentially released from the flagellar pocket region and/or at the opposite posterior end of the parasite body, and seem to be devoid of microtubules. The release is time and temperature-dependent and fixed parasites do not form trails. All attempts to inhibit trail release using drugs (antimycin A, sodium azide, cytochalasin D, nocodazole, genistein, staurosporine, EGTA) failed. The observation of trails associated with intracellular parasites and amastigotes invading Vero cells suggests that this is probably a physiological process.


Subject(s)
Trypanosoma cruzi/metabolism , Variant Surface Glycoproteins, Trypanosoma/metabolism , Animals , Chlorocebus aethiops , HeLa Cells , Humans , Microscopy, Electron, Scanning , Microscopy, Immunoelectron , Temperature , Time Factors , Trypanosoma cruzi/ultrastructure , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...